Effects of valbenazine in Huntington’s disease as measured by wearable movement sensors: A substudy of the phase 3 KINECT®-HD trial. // Parkinsonism & Related Disorders. – URL: https://www.sciencedirect.com/science/article/pii/S135380202600876X?dgcid=rss_sd_all
Effects of valbenazine in Huntington’s disease as measured by wearable movement sensors: A substudy of the phase 3 KINECT®-HD trial. Parkinsonism & Related Disorders. https://www.sciencedirect.com/science/article/pii/S135380202600876X?dgcid=rss_sd_all
“Effects of valbenazine in Huntington’s disease as measured by wearable movement sensors: A substudy of the phase 3 KINECT®-HD trial.” Parkinsonism & Related Disorders.
@article{article101138,
title = {Effects of valbenazine in Huntington’s disease as measured by wearable movement sensors: A substudy of the phase 3 KINECT®-HD trial},
journal = {Parkinsonism \& Related Disorders},
url = {https://www.sciencedirect.com/science/article/pii/S135380202600876X?dgcid=rss_sd_all}
}
npj Aging, Published online: 19 November 2026; doi:10.1038/s41514-026-00570-8 Nicotinamide deficiency in the aqueous humor of patients with glaucoma revealed by LC-MS/MS
npj Aging, Published online: 19 November 2026; doi:10.1038/s41514-026-00566-4 Organ-specific proteomic aging in Chinese adults: 20-year clinical outcomes and metabolomic underpinnings